Form 4: Danaher Officer Reports Tax Withholding, Deferred Comp

Danaher's SVP, Chief Science Officer, Jose-Carlos Gutierrez-Ramos, reported a tax-related disposition of 852 common shares and an acquisition of 275 notional shares in a deferred compensation plan.

Summary

• Jose-Carlos Gutierrez-Ramos, SVP, Chief Science Officer of Danaher Corp (DHR), reported transactions on February 2, 2026.
• Disposed of 852 shares of common stock at a price of $223.42 per share. This transaction was for tax withholding purposes in connection with the distribution of performance-based restricted stock units.
• Acquired 275 notional shares in the Danaher Deferred Compensation Programs Danaher Stock Fund, with a deemed price of $218.89 per share. This represents the company's annual contribution to the deferred compensation program.
• Following these reported transactions, Gutierrez-Ramos beneficially owns 11,304 direct common shares and 1,447.296 notional shares in the deferred compensation program.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, reflecting standard executive compensation and tax-related stock movements rather than discretionary investment decisions or significant corporate events.

Positives

• Acquisition of 275 notional shares in the deferred compensation program indicates continued participation and alignment with company performance through executive benefits.

Negatives

• Disposition of 852 shares for tax withholding reduces direct beneficial ownership, though it is a non-discretionary event common with restricted stock unit vesting.

Future Outlook

This Form 4 filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, providing transparency into executive stock holdings. The reported transactions, specifically tax-related withholdings and deferred compensation contributions, are common occurrences and generally do not signal a change in management's outlook or company fundamentals, unlike open market purchases or sales.

Comparison to Industry Standards

• These types of transactions (tax withholdings on RSU vesting and deferred compensation plan contributions) are standard practices across publicly traded companies, including peers like Thermo Fisher Scientific (TMO) or Abbott Laboratories (ABT), which also utilize similar executive compensation and deferred savings structures.
• The specific share amounts and prices reflect Danaher's compensation policies and stock performance at the time of the transaction, aligning with typical executive benefit structures seen in the life sciences and diagnostics industry.

Stakeholder Impact

• Shareholders: Provides transparency on executive stock ownership changes, which are routine and non-discretionary, offering insight into executive compensation structures.
• Employees (Executive): Reflects standard executive compensation practices, including deferred compensation and restricted stock unit vesting, which are part of their overall remuneration package.

Next Steps

• Vesting terms and the manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which are summarized in Danaher Corporation's latest annual meeting proxy statement on Schedule 14A.

Key Dates

Recommendation

The filing details routine, non-discretionary insider transactions (tax withholding and deferred compensation contributions). These events do not provide new fundamental information about Danaher's operational performance or strategic direction that would warrant a change in investment recommendation. Investors should hold their position based on broader company fundamentals and market conditions.

Keywords

Danaher, DHR, Form 4, Insider Transaction, Beneficial Ownership, Jose-Carlos Gutierrez-Ramos, Deferred Compensation, Stock Withholding, Executive Compensation